PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan.\', \'National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County 35053, Taiwan.\', \'Antaimmu BioMed Co., Ltd., Hsinchu 30078, Taiwan.\', \'Department and Institute of Physiology, National Yang-Ming University, Taipei 11221, Taiwan.\', \'Department and Institute of Physiology, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.\', \'Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli County 35053, Taiwan.\', \'Institute of Neuroscience, School of Life Science, National Yang-Ming University, Taipei 11221, Taiwan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 822610.3390/ijms22158226
?:doi
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 34360989
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • The Effects of Aβ1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all